会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 42. 发明申请
    • METHOD OF CANCER TREATMENT WITH ANTAGONISTS OF FAS INHIBITORS
    • 癌症治疗方法与FAS抑制剂的拮抗剂
    • WO2009014702A2
    • 2009-01-29
    • PCT/US2008/008914
    • 2008-07-23
    • BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMSAMANIEGO, FelipeWANG, SuizhaoWANG, Shu
    • SAMANIEGO, FelipeWANG, SuizhaoWANG, Shu
    • A61K38/17A61P35/00A61P35/02A61P37/00A61P39/00
    • A61K38/1709A61K38/10A61K38/162A61K38/1774A61K48/00C07K14/70539C07K14/82C12N15/1135C12N15/1138C12N2310/14C12N2799/027
    • In one embodiment, the present invention relates to a method of treating a cancer characterized by inhibition of Fas-mediated apoptosis, comprising administering to a patient suffering from the cancer a pharmaceutically-effective amount of a composition comprising a peptide that competitively antagonizes at least one protein-Fas binding selected from the group consisting of herpes virus 8 protein Kl binding to Fas, CD74 binding to Fas, and pi 00 binding to Fas. In a further embodiment, the peptide is selected from the group consisting of peptides having from about 15 to about 35 amino acid residues and comprising at least a portion of the immunoglobulin domain of Kl, peptides having from about 15 to about 35 amino acid residues and comprising at least fifteen consecutive amino acid residues among positions 50-120 of CD74, LVTLLLAGQ ATT A YFL YQQQ, LYQQQGRLDKLTVTSQNLQL, QNLQLENLRMKLPKPPKPVS, and PKPVSKMRMATPLLMQALPM. In another embodiment, the present invention relates to a method of treating a disease characterized by unwanted apoptosis in a mammal, comprising transfecting a cell of the mammal with a nucleic acid molecule encoding CD74. The present invention also relates to the compositions referred to above and their use in manufacture of medicaments for treatment of the diseases described herein.
    • 在一个实施方案中,本发明涉及治疗特征在于抑制Fas介导的细胞凋亡的癌症的方法,其包括向患有癌症的患者施用药物有效量的组合物,所述组合物包含竞争性拮抗至少一种 蛋白质-Fas结合选自结合Fas的疱疹病毒8蛋白K1,与Fas结合的CD74,以及结合Fas的pi 00。 在另一个实施方案中,肽选自具有约15至约35个氨基酸残基并且包含至少一部分Kl免疫球蛋白结构域的肽,具有约15至约35个氨基酸残基的肽,以及 包括CD74的位置50-120中的至少十五个连续氨基酸残基,LVTLLLAGQ ATT A YFL YQQQ,LYQQQGRLDKLTVTSQNLQL,QNLQLENLRMKLPKPPKPVS和PKPVSKMRMATPLLMQALPM。 在另一个实施方案中,本发明涉及治疗哺乳动物特征在于不希望的细胞凋亡的疾病的方法,包括用编码CD74的核酸分子转染哺乳动物细胞。 本发明还涉及上述组合物及其在制备用于治疗本文所述疾病的药物中的用途。
    • 46. 发明申请
    • CONTROL CIRCUIT WITH FAST RECOVERY
    • 快速恢复控制电路
    • WO2010043466A1
    • 2010-04-22
    • PCT/EP2009/062075
    • 2009-09-17
    • STMICROELECTRONICS SAWANG, Shu
    • WANG, Shu
    • H02M3/157H02M3/156
    • H02M3/157H02M3/156H02M2001/0012
    • The invention concerns a control circuit arranged to generate a control signal (V c ) for controlling at least one transistor of a switched mode power supply (SMPS, 102) during first, second and third successive time periods based on a feedback voltage (V F ), wherein during the first and third time periods the control circuit is adapted to regulate the output voltage of the SMPS to a first voltage level, and during the second time period the control circuit is adapted to control the SMPS to output a low voltage, the control circuit having a memory (304) adapted to store an indication of the control signal generated by the control circuit at the end of the first time period, wherein the control circuit is adapted to output a control signal based on the stored indication at the start of the third time period.
    • 本发明涉及一种控制电路,其被布置为基于反馈电压(VF)产生用于在第一,第二和第三连续时间段期间控制开关模式电源(SMPS,102)的至少一个晶体管的控制信号(Vc) 其中在所述第一和第三时间段期间,所述控制电路适于将所述SMPS的输出电压调节到第一电压电平,并且在所述第二时间段期间,所述控制电路适于控制所述SMPS以输出低电压,所述控制 电路具有适于在第一时间段结束时存储由控制电路产生的控制信号的指示的存储器(304),其中控制电路适于基于在开始时存储的指示输出控制信号 第三个时期。